Skip to main content

Table 5 Factors associated with high-risk OSA among T2DM patients in WUSH, southern Ethiopia, 2021

From: Obstructive sleep apnea risk and its associated factors among type 2 diabetes mellitus patients at wolkite university specialized hospital, Wolkite, Southern Ethiopia, 2021. A comparative cross-sectional study

Variable

Category

OSA risk (n, %)

Bivariate analysis

p-value

Multivariate

p-value

 

High-risk

Low-risk

COR (CI)

AOR (CI)

 

Sex

Male

26 (44.8)

32 (55.2)

1.29 (0.58, 2.87)

1

0.531

_______

_____

Female

17 (38.6)

27 (61.4)

Age (years), mean (± SD)

64.9 (9.9)

51.3(10.2)

1.15 (1.09, 1.23)

 < 0.001*

1.13 (1.04, 1.22)

0.002**

Marital status

Married

34 (42.5)

46 (57.5)

1.07 (0.41, 2.78)

1

0.894

________

_____

Others a

9 (40.9)

13 (59.1)

Occupation

Merchants

20 (41.7)

28 (58.3)

1.55 (0.50, 4.77)

0.633

________

_____

Housewife

10 (52.6)

9 (47.4)

2.41 (0.64, 9.03)

Others b

7 (43.8)

9 (56.2)

1.68 (0.42, 6.72)

G/ E

6 (31.6)

13 (68.4)

1

Educational status

Illiterate

8 (40.0)

12 (60)

1.00 (0.33, 2.99)

0.870

________

_____

Primary

19 (45.2)

23 (54.8)

1.24 (0.52, 2.98)

2ry and above

16 (40.0)

24 (60.0)

1

Resident

Urban

37 (40.7)

54 (59.3)

0.57 (0.16, 2.01)

0.383

_______

_____

Rural

6 (54.5)

5 (45.5)

NC (cm)

High

22 (64.7)

12 (35.3)

4.10 (1.72, 9.81)

0.001*

1.71 (0.27, 10.78)

0.567

 

Normal

21 (30.9)

47 (69.1)

1

 

1

 

Neck grasp

Positive

30 (85.7)

5 (14.3)

24.9 (8.1, 76.7)

1

 < 0001*

6.48 (1.56, 26.96)

1

0.010**

Negative

13 (19.4)

54 (80.6)

WC (cm)

C/ obesity

31 (68.9)

14 (31.1)

8.3 (3.39, 20.35)

 < 0.001*

4.44 (1.12, 17.61)

0.034**

 

Normal

12 (21.1)

45 (78.9)

1

 

1

 

BGL

Poor control

37 (47.4)

41 (52.6)

2.71 (0.97, 7.55)

1

0.057*

1.39 (0.16, 10.4)

1

0.750

Good control

6 (25.0)

18 (75.0)

T2DM duration

 > 5 years

23 (46.9)

26 (53.1)

1.46 (0.7, 3.2)

1

0.348

______

____

 ≤ 5 years

20 (37.7)

33 (62.3)

Medication

Insulin & oral

8 (57.1)

6 (42.9)

2.02 (0.65, 6.32)

1

0.228

0.52 (0.08. 3.43)

0.495

Oral alone

35 (39.8)

53 (60.2)

Complication

Yes

21 (72.4)

8 (27.6)

6.08 (2.34, 15.82)

1

 < 0.001*

4.18 (1.13, 15.43)

1

0.032**

No

22 (30.1)

51 (69.9)

Alcohol intake history

Former

7 (43.8)

9 (56.2)

0.87 (0.28, 2.66)

0.401

_______

____

Current

10 (32.3)

21 (67.7)

0.53 (0.21, 1.33)

Never

26 (47.3)

29 (52.7)

1

Chewing chat

Former

6 (60.0)

4 (40.0)

2.42(0.62, 9.41)

0.404

_______

____

Current

11 (45.8)

13 (54.2)

1.37 (0.53, 3.5)

1

Never

26 (54.2)

42 (45.8)

Sleeping pills/user

Former

9 (45.0)

11 (55.0)

1.21 (0.44, 3.35)

0.897

_______

____

Current

9 (45.0)

11 (55.0)

1.21 (0.44, 3.35)

1

Never

25 (40.3)

37 (59.7)

  1. AOR adjusted odds ratio, COR crude odds ratio, CI 95% confidence interval, OSA obstructive sleep apnea, NC neck circumference, WC waist circumference, BGL blood glucose level, T2DM type 2 diabetes mellitus, G/E government employee, C/ obesity central obesity, 2ry secondary
  2. *association in bivariate analysis, ** significant association on multivariate analysis
  3. a(widowed, single and divorced), b(farmers, unemployed), 1(reference)
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us